All stocks / EVFM
Evofem Biosciences, Inc. EVFM
Evofem Biosciences (EVFM): convertible notes mentioned in an 8-K in October 2026 and the latest annual figures in plain language. Each fact links to its SEC filing.
Market listing
- Full name
- EVOFEM BIOSCIENCES INC
- Market tier
- OTC Pink Current
- Trading status
- Active
- Last trade
- Nov 16
- Website
- www.evofem.com/
News headlines
The financial report, and what it means
Annual figures to 2025-12-31- Revenue
- $20,183,000
- Net income
- $391,000
It earned more than it spent
SteadyAfter all costs, the company kept $391,000 as profit in the year.
- Cash and cash equivalents
- $578,000
- Net cash used in operating activities
- ($1,992,000)
The cash could run out soon
Under strainIt had $578,000 in the bank and used about $166,000 a month. At that pace the money lasts about 3 months unless it borrows or sells more shares.
- Total assets
- $20,274,000
- Total liabilities
- $89,711,000
It owes more than it owns
Under strainEverything the company owns adds up to $20.3 million. Its debts and unpaid bills add up to $89.7 million. That is about $4.42 owed for every $1 owned.
What this adds up to
2 of 3 checks show strain. The cash could run out soon. It owes more than it owns. These are facts from the company's own reports, not a recommendation.
Signals
Estimated float about 132,530,081 shares as of 2026-11-09: 132,530,081 outstanding minus 0 held by 0 reporting insider(s).
Rule: Estimated: shares outstanding minus the latest holdings insiders reported on Forms 3/4/5. Holders of 5% or more (13D/13G) are not yet subtracted. Source record
8-K filed 2026-10-15 mentions: convertible note.
Rule: 8-K in the last 12 months mentioning convertible notes or an equity line. Source record
8-K filed 2026-04-16 mentions: convertible note.
Rule: 8-K in the last 12 months mentioning convertible notes or an equity line. Source record
Shares outstanding
Source: SEC filingsPrice chart
Chart by TradingView. We do not store or publish prices. Live quote on OTC Markets
Recent filings
Common questions about EVFM
Does EVFM file reports with the SEC?
Yes. Evofem Biosciences files with the SEC under company number 0001618835. The most recent filing we hold is a 10-Q dated 2026-11-13.
Source recordHow many EVFM shares are outstanding?
132,530,081 shares as of 2026-11-09, as reported to the SEC.
Source recordHas EVFM filed reports late?
We found no late-filing notices (NT 10-K or NT 10-Q) in its last 12 months of SEC filings.
Is Evofem Biosciences making money?
After all costs, the company kept $391,000 as profit in the year. (Annual figures to 2025-12-31. Facts from the company's own report, not a recommendation.)
Source record